PR
NImmune Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| omilancor | Ulcerative Colitis | Phase 3 |
Leadership Team at NImmune Biopharma
DJ
Dr. Josep Bassaganya-Riera
Executive Chairman, President, and CEO
DR
Dr. Raquel Hontecillas
Chief Scientific Officer
DA
Dr. Andrew Leber
Chief Development Officer
MC
Marek Ciszewski, JD
Chief Financial Officer
DN
Dr. Nuria Tubau-Juni
VP of Inflammation and Immunology